Las Vegas, NV -- (SBWIRE) -- 01/08/2014 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks: Daimler AG (USA)(OTCMKTS:DDAIF), Dewmar International BMC Inc(OTCMKTS:DEWM), FUSE SCIENCE, INC(OTCMKTS:DROP), Capricor Therapeutics Inc(OTCMKTS:CAPR)
Daimler AG (USA)(OTCMKTS:DDAIF) ended higher 1.18% and complete the day at $84.71. The total number of shares changed hands during the day was 28,514. After opening at $84.67, the stock hit as high as $85.15. However, it traded between $49.72 and $87.39 over the last twelve months. Daimler AG is a Germany-based company that develops, manufactures and distributes a range of automotive products, mainly passenger cars, trucks, vans and buses, as well as manages the Daimler Group
For How Long DDAIF will Fight for Profitability? Read This Trend Analysis report
Dewmar International BMC Inc(OTCMKTS:DEWM) closed yesterday at $0.0006, a 20.00% increase. Around 210.29million shares were traded, beating an-average trading volume of 205.52 million shares. The company is now valued at around $254,765. Dewmar International BMC, Inc., formerly Convenientcast, Inc., focuses on searching for properties of merit to acquire and develop. On June 9, 2009, the Company sold its interest in the Big Andy Mine.
For How Long DEWM Gloss will Attract Investors? Find out via this report
FUSE SCIENCE, INC(OTCMKTS:DROP) moved +3.12 percent higher at $0.0165 and traded between $0.01 and $0.02 after opening the day at $0.02. Its performance over the last five days remained -28.26%, which stands at -31.82% for a month. Going back further than one month, 1-year performance after recent close was -28.26%. Fuse Science, Inc., a consumer products company, develops alternative delivery systems with applications in the sports nutrition and medical fields. Its delivery systems include sublingual and transdermal delivery technologies that enable energy, medicines, vitamins, and minerals to bypass the gastrointestinal tract and enter the blood stream directly.
For How Long DROP Gloss will Attract Investors? Find out via this report
Capricor Therapeutics Inc(OTCMKTS:CAPR) shares rose, gaining +43.28 percent to close at $7.25. The stock is up around 123.08% this year and 11983.33% for the last 12 months. Around 69,511 shares changed hands yesterday, higher from an-average trading volume of 6,775 shares. Capricor Therapeutics, Inc., formerly Nile Therapeutics, Inc., is a development stage biopharmaceutical company.
Why Should Investors Buy CAPR After The Recent Gain? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)